Pharma Industry Mixed on Off-Year Drug Price Revision Plan for FY2023

December 19, 2022
People in the Japanese pharmaceutical and wholesaler industry on December 16 aired mixed responses to the government’s plan for “off-year” drug re-pricing next April. Some are relieved to see special measures for unprofitable products and on-patent meds, while others are...read more